Structure-switching Aptamer Nanosensor for Therapeutic Drug Monitoring of Methotrexate in Diluted Serum
The MTX fluorescence assay developed in this study offers advantages, including ease of use, high sensitivity, and good selectivity, and holds significant potential for clinical drug monitoring in MTX therapy.